Erasca, Inc. (ERAS)
10.00
-0.65
(-6.10%)
USD |
NASDAQ |
May 01, 16:00
10.08
+0.08
(+0.80%)
After-Hours: 19:05
Erasca EPS Diluted (Quarterly) : -0.1025 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | -0.2945 |
| Incyte Corp. | 1.467 |
| Tonix Pharmaceuticals Holding Corp. | -3.976 |
| Karyopharm Therapeutics, Inc. | -5.708 |
| Syndax Pharmaceuticals, Inc. | -0.7786 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.09M |
| Total Expenses (Quarterly) | 29.09M |
| Enterprise Value | 3.081B |
| Earnings Yield | -4.39% |
| Normalized Earnings Yield | -4.158 |